Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

STIM

Neuronetics (STIM)

Neuronetics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:STIM
DateTimeSourceHeadlineSymbolCompany
06/13/20247:31AMGlobeNewswire Inc.NeuroStar Showcases Cutting-Edge Research at Clinical TMS Society Annual MeetingNASDAQ:STIMNeuronetics Inc
06/06/20245:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:STIMNeuronetics Inc
06/05/20247:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STIMNeuronetics Inc
06/05/20247:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STIMNeuronetics Inc
06/03/20243:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:STIMNeuronetics Inc
05/30/20243:01PMEdgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:STIMNeuronetics Inc
05/23/20247:30AMGlobeNewswire Inc.Neuronetics to Present at the William Blair 44th Annual Growth Stock ConferenceNASDAQ:STIMNeuronetics Inc
05/15/20246:32AMGlobeNewswire Inc.Humana Is First Commercial Payer to Address TMS Therapy Coverage for AdolescentsNASDAQ:STIMNeuronetics Inc
05/07/20243:31PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:STIMNeuronetics Inc
05/07/20246:31AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:STIMNeuronetics Inc
05/07/20246:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:STIMNeuronetics Inc
05/07/20246:30AMGlobeNewswire Inc.Neuronetics Reports Record First Quarter 2024 Financial and Operating ResultsNASDAQ:STIMNeuronetics Inc
05/03/20243:30PMGlobeNewswire Inc.Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:STIMNeuronetics Inc
05/01/20247:31AMGlobeNewswire Inc.NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness MonthNASDAQ:STIMNeuronetics Inc
04/23/20243:30PMGlobeNewswire Inc.Neuronetics to Report First Quarter 2024 Financial and Operating Results and Host Conference CallNASDAQ:STIMNeuronetics Inc
04/10/20247:31AMGlobeNewswire Inc.New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is VitalNASDAQ:STIMNeuronetics Inc
03/27/20243:30PMGlobeNewswire Inc.Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:STIMNeuronetics Inc
03/25/20247:30AMGlobeNewswire Inc.NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with DepressionNASDAQ:STIMNeuronetics Inc
03/07/20247:22AMGlobeNewswire Inc.Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care NetworkNASDAQ:STIMNeuronetics Inc
03/06/20243:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:STIMNeuronetics Inc
03/05/20246:31AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:STIMNeuronetics Inc
03/05/20246:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:STIMNeuronetics Inc
03/05/20246:30AMGlobeNewswire Inc.Neuronetics Reports Record Fourth Quarter and Record Full Year 2023 Financial and Operating ResultsNASDAQ:STIMNeuronetics Inc
03/01/20244:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STIMNeuronetics Inc
03/01/20244:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STIMNeuronetics Inc
02/29/20244:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STIMNeuronetics Inc
02/29/20243:10PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STIMNeuronetics Inc
02/28/20244:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STIMNeuronetics Inc
02/28/20243:48PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STIMNeuronetics Inc
02/28/20243:16PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STIMNeuronetics Inc
 Showing the most relevant articles for your search:NASDAQ:STIM